525 related articles for article (PubMed ID: 23478530)
21. [Surgical outcomes for 187 patients with locally recurrent rectal cancer and analysis of prognostic factors].
Jiang Y; Wan YL; Liu YC; Wang X; Pan YS; Wu T; Wang PY; Huang SJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):582-5. PubMed ID: 21866446
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer.
Larsen SG; Wiig JN; Dueland S; Giercksky KE
Eur J Surg Oncol; 2008 Apr; 34(4):410-7. PubMed ID: 17614249
[TBL] [Abstract][Full Text] [Related]
23. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
24. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
25. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
26. Determinants of survival following pelvic exenteration for primary rectal cancer.
Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
[TBL] [Abstract][Full Text] [Related]
27. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
28. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
29. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
30. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
[TBL] [Abstract][Full Text] [Related]
31. Outcome after curative resection for locally recurrent rectal cancer.
Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
[TBL] [Abstract][Full Text] [Related]
32. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
33. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
PelvEx Collaborative
Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
[TBL] [Abstract][Full Text] [Related]
34. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
Larsen SG; Wiig JN; Tretli S; Giercksky KE
Colorectal Dis; 2006 Mar; 8(3):177-85. PubMed ID: 16466556
[TBL] [Abstract][Full Text] [Related]
35. Posterior pelvic exenteration for primary rectal cancer.
Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
[TBL] [Abstract][Full Text] [Related]
36. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
[TBL] [Abstract][Full Text] [Related]
37. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
[TBL] [Abstract][Full Text] [Related]
38. Outcome of surgical resection of second-time locally recurrent rectal cancer.
Harji DP; Sagar PM; Boyle K; Maslekar S; Griffiths B; McArthur DR
Br J Surg; 2013 Feb; 100(3):403-9. PubMed ID: 23225371
[TBL] [Abstract][Full Text] [Related]
39. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
40. [Total pelvic exenteration for primary and locally recurrent rectal cancer].
Takagi H; Morimoto T; Kato T; Yasue M; Kato K; Yamada E; Hara S; Kido C; Suzuki R; Kuwabara M
Gan No Rinsho; 1984 Nov; 30(14):1779-85. PubMed ID: 6513031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
